Search

Memorial Sloan Kettering has made an important step forward in efficiently diagnosing gene mutations in patients' cancers on an individual basis.

… Tuesday, June 1, 2010 Summary Memorial Sloan Kettering has made an important step forward in efficiently diagnosing gene mutations in patients’ cancers on an individual basis. As the number of targeted cancer therapies grows, it is becoming increasingly important that hospital laboratories be able to

During World War II, US factories famously converted their operations to support the war effort. COVID-19 instigated something similar among cancer scientists.

… Friday, January 8, 2021 Summary When COVID-19 hit, cancer researchers at MSK used their expertise in genomics to help solve the mystery of how the virus infects human cells. “I remember thinking I wanted to do something,” recalls Francisco J. Sánchez-Rivera , a postdoctoral fellow in Scott Lowe’s lab

A number of Gerstner Sloan Kettering students working in labs across MSK have received prestigious fellowships granted by external agencies and benefactors of the school.

… Friday, August 29, 2025 This past year, seven PhD students enrolled in the  Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) were awarded competitive fellowships from prestigious external agencies such as the National Institutes of Health (NIH) and the National Science Foundation

Memorial Sloan Kettering Cancer Center and MediSys Health Network today announced a new collaboration that will expand access to world-class cancer care for the people of Queens and eastern Brooklyn.

… Thursday, January 12, 2023 Memorial Sloan Kettering Cancer Center (MSK) and MediSys Health Network (Jamaica Hospital Medical Center and Flushing Hospital Medical Center) today announced a new collaboration that will expand access to world-class cancer care for the people of Queens and eastern Brooklyn

By sequencing the entire genome of a tumor, the experimental test will go beyond standard testing for common cancers in adults.

… Wednesday, May 18, 2022 New findings from researchers at Memorial Sloan Kettering Cancer Center (MSK) and published today in the journal Nature Communications report the results of using a comprehensive sequencing approach on 114 pediatric, adolescent, and young adult patients with solid tumors. The

Naxitamab was created at MSK and has received Breakthrough Therapy Designation from the FDA.

… Friday, September 28, 2018 Summary Naxitamab was created at MSK and has received Breakthrough Therapy Designation from the FDA for the treatment of patients with high-risk neuroblastoma. Neuroblastoma is a rare cancer of the nerve tissue that usually arises in the abdomen. It mainly affects young children

Learn how a new cancer engineering PhD program is attracting leading scientists to come to MSK.

… Friday, September 13, 2024 A visionary new approach to solving problems in cancer science is now fully underway at Memorial Sloan Kettering Cancer Center (MSK), as the inaugural class begins  the Pat and Ian Cook Doctoral Program in Cancer Engineering . Leading researchers — drawn to MSK by the opportunity

Following an approval from the FDA in May 2020, the New England Journal of Medicine has published data from the phase I/II LIBRETTO-001 clinical trial of selpercatinib in advanced RET (REarranged during Transfection)-driven lung and thyroid cancers. MSK’s Alexander Drilon, MD, the recently appointed Chief of the Early Drug Development Service, serves as the lead investigator for multi-site clinical trial.

… Wednesday, August 26, 2020 Results Mark Significant Advances in Targeted Treatment for RET-Driven Cancers, Advancing the Field of Precision Medicine Following an approval from the U.S. Food and Drug Administration (FDA) in May 2020, the New England Journal of Medicine has published data from the phase

Two intraperitoneal chemotherapy approaches are being compared for effectiveness and toxicity in Memorial Sloan Kettering Cancer Center’s phase II clinical trial, which continues to enroll cytoreductive cancer surgery patients with isolated peritoneal metastasis.

… Thursday, May 19, 2016 After surgical cytoreduction Figure 1. After surgical cytoreduction, percutaneous inflow and outflow catheters and IP temperature probes are placed in the peritoneal cavity. The catheters are connected to the perfusion system, and normal saline is heated to 41-43°C and circulated

Whether you’ve been diagnosed with a rare cancer or one that’s more common, MSK doctors can provide a second opinion.

… Thursday, December 18, 2025 Learning that you have cancer can be an overwhelming experience. As you begin researching what steps to take after receiving a  cancer diagnosis , you’ll probably hear a lot about getting a second opinion. Memorial Sloan Kettering Cancer Center (MSK) provides second opinions